High resolution structures of HIV-1 RT from four RT—inhibitor complexes

Nature Structural Biology

Volumn 2, Issue 4, 1995, Pages 293-302

  Ren, Jingshan ^a   Esnouf, Robert ^a,b   Garman, Elspeth ^a   Somers, Donald ^c   Ross, Carl ^c   Kirby, Ian ^c   Keeling, James ^c   Darby, Graham ^c   Jones, Yvonne ^a,b   Stuart, David ^a,b   Stammers, David ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACYCLOURIDINE DERIVATIVE; COMPOUND 1051U91; ENZYME INHIBITOR; NEVIRAPINE; R 90385; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CRYSTALLOGRAPHY; DRUG DESIGN; ENZYME ACTIVITY; ENZYME STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; BINDING SITES; COMPARATIVE STUDY; COMPUTER GRAPHICS; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEVIRAPINE; POINT MUTATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PYRIDINES; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE INHIBITORS; RNA-DIRECTED DNA POLYMERASE; SUPPORT, NON-U.S. GOV'T;

EID: 0028947588     PISSN: 10728368     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsb0495-293     Document Type: Article

References (49)

1. Barre-Sinoussi, F. et al. Isolation of a T-lymphotroplc retrovirus from a patient at risk from acquired Immunodeficiency syndrome (AIDS). Science 220, 868-871 (1983).
2. Larder, B.A. and Kemp, S.D. Multiple mutations In HIV-1 reverse transcriptase confer high-level resistance to Zidovudine (AZT). Science 246, 1155-1158 (1989).
3. Baba, M. et al. Highly specific Inhibition of human Immunodeficiency virus type-1 by a novel 6-substltuted acyclourldlne derivative, blochem. Biophys. Res. Commun. 165, 1375-1381 (1989).
4. Pauwels, R. et al. Potent and selective Inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 343, 470-474(1990).
5. Merluzzl, V.J et al. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science 250, 1411-1413 (1990).
6. Pauwels, R. et al. Potent and highly selective HIV-1 inhibition by a new series of a-anlllno phenyl acetamide (a-APA) derivatives targeted at HIV-1 reverse transcriptase. Proc. natn. Acad. Sci. U.S.A. 90, 1711-1715 (1993).
7. Wu, J.C. et al. A novel dlpyrldodlazeplnone inhibitor of HIV-1 reverse transcriptase acts through a non-substrate binding site. Biochemistry 30, 2022-2026 (1991).
8. Debyser, Z. et al. An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimldazo- [4, 5 1-jk][1, 4]benzodlazeplne-2(1H)-one and-thlone derivatives. Proc. natn. Acad. Sci. U.S.A. 88, 1451-1455 (1991).
9. Kohlstaedt, L.A., Wang, J., Friedman, J.M., Rice, P.A. and Steltz, T.A. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256, 1783-1790 (1992).
10. Rlchman, D.et al. Human Immunodeficiency virus type 1 mutants resistant to non-nucleoside Inhibitors of reverse transcriptase arise In tissue culture. Proc. natn. Acad. Sci. U.S.A. 88, 11241-11245 (1991).
11. Rlchman, D.D. et al. Nevirapine resistance mutations of Immunodeficiency virus type 1 selected during therapy. J. Virol. 68, 1660-1666(1994).
12. Larder, B.A. Interactions between drug resistance mutations In human Immunodeficiency virus type 1 reverse transcriptase. J. gen. Virol. 75, 951-957 (1994).
13. De Clercq, E. HIV resistance to reverse transcriptase inhibitors. Blochem. Pharmacol. 47, 1 55-169 (1994).
14. Schinazl, R., Larder, B.A. and Mellors, J. Mutations In HIV-1 reverse transcriptase and protease associated with drug resistance. Int. Antiviral News 2, 72-75 (1994).
15. Jones, E.Y. et al. The growth and characterization of crystals of human Immunodeficiency virus (HIV) reverse transcriptase. J. crystal Growth 126, 261-269 (1993).
16. Smerdon, S.J. et al. Structure of the binding site for nonnucleoside Inhibitors of the reverse transcriptase of human Immunodeficiency virus type 1. Proc. natn. Acad. Sci. U.S.A. 91, 3911-3915 (1994).
17. Jacobo-Mollna, A. et al. Crystal structure of human Immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Â resolution shows bent DNA. Proc. natn. Acad. Sci. U.S.A. 90, 6320-6324 (1993).
18. Unge, T. et al. 2.2 A resolution structure of the amino-terminal half of HIV-1 reverse transcriptase (fingers and palm subdomains). Structure 2, 953-961 (1994).
19. Davies, I.J.F, Hostomska, Z., Hostomsky, Z., Jordan, S.R. and Matthews, D. A. Crystal structure of the Ribonucléase H domain of HIV-1 reverse transcriptase. Science, 252, 88-95 (1991).
20. Hargrave, K.D. et al. Novel non-nucleoside Inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyrldobenzo- and dlpyrldodlaze- pinones. J. med. Chem. 34, 2231-2241 (1991).
21. Esnouf, R. et al. Mechanism of inhibition of HIV-1 reverse transcriptase by Non-nucleoside Inhibitors. Nature struct. Biol. 2, 303-308 (1995).
22. Stammers, D.K. et al. Crystals of HIV-1 reverse transcriptase diffracting to 2.2 À resolution. J. molec. Biol. 242, 586-588 (1994).
23. Yuasa, S. et al. Selective and synergistic Inhibition of human Immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442. Molec. Pharmacol 44, 895-900(1993).
24. Balzarlnl, J., Karlsson, A. and De Clercq, E. Human Immunodeficiency virus type 1 drug-resistance patterns with different 1-[- hydroxyethoxymethyl]-6-phenylthlothymine derivatives. Molec. Pharmacol. 44, 694-701 (1993).
25. Byrnes, V.W. et al. Comprehensive mutant enzyme and viral variant assessment of human Immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside Inhibitors. Antimicrob. Agents Chemother. 37, 1576-1579(1993).
26. Balzarinl, J. et al. HIV-1 specific reverse transcriptase Inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase. Virology 192, 246-253 (1993).
27. Balzarlni, J. et al. Human Immunodeficiency virus 1 HIV-1 -specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant E138K RT HIV-1 mutants or select for highly resistant Y181C-0811 RT HIV-1 mutants. Proc. natn. Acad. Sci. U.S.A. 91, 6599-6603 (1994).
28. Mellors, J.W. etal. Rapid emergence of HIV-1 resistant to nonnucleoside Inhibitors of reverse transcriptase. Antiviral Res. 17 31-48
29. Sardana, V.V. et al. Functional analysis of HIV-1 reverse transcriptase amino acids Involved In resistance to multiple nonnucleoside inhibitors. J. biol. Chem. 267, 17526-17530(1992).
30. Dueweke, T.J. et al. A mutation In reverse transcriptase of bisheteroarylplperazlne-reslstant human Immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors. Proc. natn. Acad. Sci. U.S.A. 90, 4713-4717 (1993).
31. Maass, G. etal. Viral resistance to the thlazolo-lso-lndollneones, a new class of nonnucleoside Inhibitors of human Immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 37, 2612-2617(1993).
32. Vandamme, A.-M., et al. Characterization of HIV-1 strains isolated from patients treated with TIBO R82913. AIDS Res. hum. Retroviruses 10, 39-46 (1994).
33. Balzarlni, J. et al. Treatment of human Immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1 -specific Inhibitors results In a different resistance pattern than does treatment with single-drug therapy J. Virol. 67, 5353-5359 (1993).
34. Nunberg, J.H. et al. Viral resistance to human immunodeficiency virus type-1-specific pyrldlnone reverse transcriptase Inhibitors J. Virol. 65, 4887-4892 (1991).
35. Jacques, P.S., Wohrl, B.M., Howard, K.J. and Le Grice, S.F.J. Modulation of HIV-1 reverse transcriptase function In "selectively deleted" p66/p51 heterodimers J. biol. Chem. 269, 1388-1393(1994).
36. Sakabe, N. X-ray diffraction data collection system for modern protein crystallography with a Welssenberg camera and an Imaging plate using synchrotron radiation. Nucl. instr. Methods phys. Res 303, 448-463 (1991).
37. Stuart, D.l. and Jones, E.Y. Welssenberg data collection for macromolecular crystallography. Curr. Opin. struct. Biol. 3, 737-740
38. Higashi, T.J. Auto-indexing of oscillation Images. J. appl. Crystallogr. 23, 253-257 (1990).
39. Otwlnowski, Z., Oscillation data reduction program, in Data collection and Processing (eds. Sawyer, L., Isaacs, N. and Bailey, S.) 5662 (SERC Daresbury Laboratory, Warrington, England; 1993).
40. Brunger, A.T. V3.X-PLOR Manual. (Yale University, New Haven, CT; 1992).
41. CCP4. The CCP4 suite; programs for protein crystallography Acta crystallogr. D50, 760-763 (1994).
42. Brunger, A.T., Krukowskl, A. and Erickson, J. Slow-cooling protocols for crystallographic refinement by simulated annealing. Acta crystallogr. A46, 585-593 (1990).
43. Jones, T.A. Interactive computer graphics: FRODO. Meths Enzymol. 115, 157-171 (1985).
44. Debyser, Z. et al. Allosteric Inhibition of human immunodeficiency virus type 1 reverse transcriptase by tetrahydrolmldazo[4, 5, 1 - jk][1, 4]benzodIazepIn-2(1 H)-one and -thione compounds. Molec. Pharmacol. 41, 203-208 (1992).
45. Stuart, D.L, Levine, M., Mulrhead, H. and Stammers, D.K. The crystal Structure of cat pyruvate kinase at a resolution of 2.6 A. J. molec. Biol. 134, 109-142 (1979).
46. Jones, T.A., Zou, J.Y., Cowan, S.W. and Kjeldgaard, M. Improved methods for building protein models In electron density maps and the location of errors In these models. Acfa crystallogr A47, 110-119 (1991).
47. Kabsch, W. and Sander, C. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22, 2577-2637 (1983).
48. Kraulls, P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. appl. Crystallogr. 24, 946-950 (1991).
49. Merritt, E.A. and Murphy, M.E.P. Raster3D version 2.0. A program for photorealistic molecular graphics. Acfa crystallogr. D50, 869-873 (1994).